Skip to main content

Table 1 The expression of STC1 related to clinicopathological features in HCC patients

From: The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma

Clinical features

High STC1 (n = 38)

Low STC1 (n = 34)

P-value

Age

   

 Young (≤ median, 52)

23

19

0.83

 Old (> medium, 52)

15

15

 

Gender

   

 Male

32

29

0.35

 Female

6

5

 

Overall survival, median, months

18.5 months

37 months

0.0051**

HBsAg

   

 Negative

10

7

0.28

 Positive

28

27

 

Serum AFP (ng/ml)

   

 Low (≤ 20)

15

12

0.32

 High (> 20)

23

22

 

Differentiation status

   

 Well differentiation

9

13

0.08

 Moderately to poorly differentiation

29

21

 

Tumor size

   

 Small (≤ 5 cm)

7

10

0.17

 Large (> 5 cm)

31

24

 

TNM stagea

   

 Early stage (I–II)

27

26

0.011*

 Advanced stage (III–IV)

11

8

 

Lymph node metastasis

   

 Absence

29

30

0.75

 Presence

9

4

 

Vascular infiltration

   

 Absence

30

32

0.26

 Presence

8

2

 
  1. aAJCC/UICC T staging system
  2. *p < 0.05, **p < 0.01, significant difference (χ2 test and Fisher’s exact test)